durapatite has been researched along with Infections, Pseudomonas in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albanese, D; Capparelli, R; Capuano, F; Malvano, F; Montone, AMI; Papaianni, M | 1 |
| Bartoszewicz, M; Chodaczek, G; Czajkowska, J; Duda-Madej, A; Dziadas, M; Fijałkowski, K; Junka, A; Krasowski, G; Mikołajewicz, K; Szymczyk, P; Żywicka, A | 1 |
| Brownstein, S; Dorey, MW; Jordan, DR | 1 |
| Hsu, WM; Kao, SC; Liu, JH; Tsai, CC; Yeh, LK | 1 |
4 other study(ies) available for durapatite and Infections, Pseudomonas
| Article | Year |
|---|---|
Lactoferrin, Quercetin, and Hydroxyapatite Act Synergistically against
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Durapatite; Humans; Lactoferrin; Nanoparticles; Pseudomonas fluorescens; Pseudomonas Infections; Quercetin; U937 Cells | 2021 |
Potential of Biocellulose Carrier Impregnated with Essential Oils to Fight Against Biofilms Formed on Hydroxyapatite.
Topics: Anti-Bacterial Agents; Biofilms; Cellulose; Durapatite; Eucalyptus; Humans; Oils, Volatile; Polysaccharides, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Syzygium; Thymus Plant | 2019 |
One patient with infection at different times of 2 hydroxyapatite implants, each requiring explantation.
Topics: Biocompatible Materials; Device Removal; Durapatite; Eye, Artificial; Humans; Male; Middle Aged; Prosthesis-Related Infections; Pseudomonas Infections; Recurrence | 2003 |
Delayed-onset of Pseudomonas infection in a hydroxyapatite orbital implant: a case report.
Topics: Adult; Durapatite; Female; Humans; Orbit; Orbit Evisceration; Prostheses and Implants; Pseudomonas Infections; Time Factors | 1999 |